Logo image of TEAD

TEADS HOLDING CO (TEAD) Stock Fundamental Analysis

USA - NASDAQ:TEAD - US69002R1032 - Common Stock

1.66 USD
-0.06 (-3.49%)
Last: 9/25/2025, 8:02:43 PM
1.66 USD
0 (0%)
Pre-Market: 9/26/2025, 4:40:04 AM
Fundamental Rating

3

Overall TEAD gets a fundamental rating of 3 out of 10. We evaluated TEAD against 0 industry peers in the Unkown industry. TEAD has a bad profitability rating. Also its financial health evaluation is rather negative. TEAD is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

TEAD had negative earnings in the past year.
TEAD had a positive operating cash flow in the past year.
In multiple years TEAD reported negative net income over the last 5 years.
Each year in the past 5 years TEAD had a positive operating cash flow.
TEAD Yearly Net Income VS EBIT VS OCF VS FCFTEAD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

1.2 Ratios

Industry RankSector Rank
ROA -3.53%
ROE -11.77%
ROIC N/A
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
TEAD Yearly ROA, ROE, ROICTEAD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

In the last couple of years the Gross Margin of TEAD has remained more or less at the same level.
TEAD does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.29%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
TEAD Yearly Profit, Operating, Gross MarginsTEAD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 10 15 20

More info and screens

2

2. Health

2.1 Basic Checks

The number of shares outstanding for TEAD has been increased compared to 1 year ago.
The number of shares outstanding for TEAD has been reduced compared to 5 years ago.
There is no outstanding debt for TEAD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
TEAD Yearly Shares OutstandingTEAD Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
TEAD Yearly Total Debt VS Total AssetsTEAD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

TEAD has an Altman-Z score of 0.46. This is a bad value and indicates that TEAD is not financially healthy and even has some risk of bankruptcy.
The Debt to FCF ratio of TEAD is 10.48, which is on the high side as it means it would take TEAD, 10.48 years of fcf income to pay off all of its debts.
A Debt/Equity ratio of 1.17 is on the high side and indicates that TEAD has dependencies on debt financing.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 10.48
Altman-Z 0.46
ROIC/WACCN/A
WACCN/A
TEAD Yearly LT Debt VS Equity VS FCFTEAD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

TEAD has a Current Ratio of 1.10. This is a normal value and indicates that TEAD is financially healthy and should not expect problems in meeting its short term obligations.
TEAD has a Quick Ratio of 1.10. This is a normal value and indicates that TEAD is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.1
Quick Ratio 1.1
TEAD Yearly Current Assets VS Current LiabilitesTEAD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for TEAD have decreased strongly by -350.00% in the last year.
Looking at the last year, TEAD shows a quite strong growth in Revenue. The Revenue has grown by 19.67% in the last year.
TEAD shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.30% yearly.
EPS 1Y (TTM)-350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
Revenue 1Y (TTM)19.67%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%60.21%

3.2 Future

The Earnings Per Share is expected to grow by 85.30% on average over the next years. This is a very strong growth
Based on estimates for the next years, TEAD will show a quite strong growth in Revenue. The Revenue will grow by 15.16% on average per year.
EPS Next Y-992.5%
EPS Next 2Y200.02%
EPS Next 3Y85.3%
EPS Next 5YN/A
Revenue Next Year51.9%
Revenue Next 2Y25.56%
Revenue Next 3Y17.86%
Revenue Next 5Y15.16%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
TEAD Yearly Revenue VS EstimatesTEAD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B
TEAD Yearly EPS VS EstimatesTEAD Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TEAD. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 4.61, the valuation of TEAD can be described as very cheap.
TEAD's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.64.
Industry RankSector Rank
PE N/A
Fwd PE 4.61
TEAD Price Earnings VS Forward Price EarningsTEAD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF 1.38
EV/EBITDA 27.14
TEAD Per share dataTEAD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

A more expensive valuation may be justified as TEAD's earnings are expected to grow with 85.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y200.02%
EPS Next 3Y85.3%

More info and screens

0

5. Dividend

5.1 Amount

TEAD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TEADS HOLDING CO

NASDAQ:TEAD (9/25/2025, 8:02:43 PM)

Premarket: 1.66 0 (0%)

1.66

-0.06 (-3.49%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner Change-6.04%
Market Cap0
Analysts76.36
Price Target3.08 (85.54%)
Short Float %N/A
Short Ratio6.97
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-151.5%
Min EPS beat(2)-198.22%
Max EPS beat(2)-104.78%
EPS beat(4)1
Avg EPS beat(4)-7.8%
Min EPS beat(4)-198.22%
Max EPS beat(4)288.62%
EPS beat(8)5
Avg EPS beat(8)507.08%
EPS beat(12)7
Avg EPS beat(12)318.71%
EPS beat(16)9
Avg EPS beat(16)228.66%
Revenue beat(2)1
Avg Revenue beat(2)-2.07%
Min Revenue beat(2)-4.5%
Max Revenue beat(2)0.36%
Revenue beat(4)1
Avg Revenue beat(4)-3.89%
Min Revenue beat(4)-7.65%
Max Revenue beat(4)0.36%
Revenue beat(8)1
Avg Revenue beat(8)-4.68%
Revenue beat(12)4
Avg Revenue beat(12)-2.82%
Revenue beat(16)7
Avg Revenue beat(16)-1.84%
PT rev (1m)-42.26%
PT rev (3m)N/A
EPS NQ rev (1m)-497.6%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)-4.81%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-2.37%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.61
P/S 0.08
P/FCF 1.38
P/OCF 1.02
P/B 0.15
P/tB N/A
EV/EBITDA 27.14
EPS(TTM)-0.18
EYN/A
EPS(NY)0.36
Fwd EY21.69%
FCF(TTM)1.2
FCFY72.32%
OCF(TTM)1.63
OCFY98.2%
SpS22.06
BVpS10.79
TBVpS-10.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.53%
ROE -11.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.29%
FCFM 5.44%
ROA(3y)-0.58%
ROA(5y)0.02%
ROE(3y)-2.34%
ROE(5y)-0.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.01%
GM growth 5Y0.91%
F-Score4
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 10.48
Debt/EBITDA 33.55
Cap/Depr 51.64%
Cap/Sales 1.95%
Interest Coverage N/A
Cash Conversion 434.71%
Profit Quality N/A
Current Ratio 1.1
Quick Ratio 1.1
Altman-Z 0.46
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)94.29%
Cap/Depr(5y)88.52%
Cap/Sales(3y)2.24%
Cap/Sales(5y)2.01%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-350%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-300%
EPS Next Y-992.5%
EPS Next 2Y200.02%
EPS Next 3Y85.3%
EPS Next 5YN/A
Revenue 1Y (TTM)19.67%
Revenue growth 3Y-4.31%
Revenue growth 5Y5.3%
Sales Q2Q%60.21%
Revenue Next Year51.9%
Revenue Next 2Y25.56%
Revenue Next 3Y17.86%
Revenue Next 5Y15.16%
EBIT growth 1Y-475.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3702.16%
EBIT Next 3Y261.82%
EBIT Next 5Y151.23%
FCF growth 1Y276.49%
FCF growth 3Y11.78%
FCF growth 5Y51.85%
OCF growth 1Y686.46%
OCF growth 3Y6.5%
OCF growth 5Y32.58%